Icariin

• Catalog No.: Bio-0292
• CAS Number: 489-32-7
• M. F.: C33H40O15
• M. W.: 676.6617

SYNONYMS

• IUPAC name: 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one
• IUPAC Traditional name: 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one
• Synonyms: 4'-Me ether, 3-O-alpha- L -rhamnopyranoside; 7-O-beta-D-glucopyranoside

DATABASE IDS

• CAS Number: 489-32-7

PROPERTIES

• Application(s): Immunostimulant
• Application(s): Antineoplastic agent
• Biological Source: Isol. from Epimedium spp.
• Mechanism of Action: Neuronal injury inhibitor
• Mechanism of Action: Calcium regulator

REFERENCES

• Jain, A.C. et al., Aust. J. Chem., 1975, 28, 607, (synth)
• Miyaichi, Y. et al., Yakugaku Zasshi, 1994, 114, 186
• He, W. et al., Arzneim.-Forsch., 1995, 45, 910-913, (Icariin, pharmacol)
• Anam, E.A., Indian J. Heterocycl. Chem., 1997, 7, 59-62
• Jiyun, L. et al., Drugs of the Future, 1998, 23, 142-145, (Icariin, rev, pharmacol)